IL6 and Sepsis: In the present study, we evaluated the accuracy and usefulness of CPD, NE-SFL and NE-WY, as biomarkers for culture-proven bacteremia in hospitalized patients, in comparison with the other commercialized sepsis biomarkers in Japan, including CRP, PCT, presepsin, and IL-6.